Smith Group Asset Management’s HYPERION THERAPEUTICS INC COM STK (DE) HPTX Stock Holding History

Smith Group Asset Management’s Portfolio HPTX Stock Details HPTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-30,070	Closed	-$1.38M	–	454
2015 Q1	$1.38M	Buy	30,070 +970	+3%	+$29K	0.05%	157
2014 Q4	$698K	Sell	29,100 -2,900	-9%	-$65.4K	0.02%	196
2014 Q3	$807K	Sell	32,000 -110	-0.3%	-$2.73K	0.03%	184
2014 Q2	$838K	Buy	+32,110	New	+$825K	0.03%	185

Smith Group Asset Management's HPTX Position: Q2 2015 in Review

Smith Group Asset Management sold out of HYPERION THERAPEUTICS INC COM STK (DE) (HPTX) in Q2 2015, closing a stake of 30,070 shares — an estimated $1.38M sold.

Smith Group Asset Management first reported a position in HPTX in Q2 2014 and held it in 4 quarters. The position peaked at $1.38M in Q1 2015. 0 funds tracked by Wall St. Rank hold HPTX as of Q2 2015.

Smith Group Asset Management reported no remaining HYPERION THERAPEUTICS INC COM STK (DE) position as of Q2 2015 after selling out during the quarter.
Smith Group Asset Management sold 30,070 HYPERION THERAPEUTICS INC COM STK (DE) shares in Q2 2015, an estimated $1.38M.
Smith Group Asset Management first reported a position in HYPERION THERAPEUTICS INC COM STK (DE) in Q2 2014 and held it in 4 quarters.
Smith Group Asset Management's HYPERION THERAPEUTICS INC COM STK (DE) position peaked at $1.38M in Q1 2015.
0 funds tracked by Wall St. Rank held HYPERION THERAPEUTICS INC COM STK (DE) as of Q2 2015.

Based on Smith Group Asset Management's 13F filing for Q2 2015, filed 29 Jul 2015.